Abstract
Background:  Plasminogen activator inhibitor (PAI)‐1 plays an important role in inflammation and tissue remodeling. Recently, the −675 4G/5G PAI‐1 polymorphism has been linked with asthma.Objective:  This study was undertaken to evaluate associations of the −675 4G/5G PAI‐1 polymorphism with functional and immunologic parameters of newly diagnosed house dust mite‐sensitive allergic asthmatics (HDM‐AAs).Methods:  This study was performed in 127 HDM‐AAs, who responded with at least 20% fall of forced expiratory volume during the first second (FEV1) to a bronchial challenge with Dermatophagoides pteronyssinus allergen and during the follow up observation fulfilled GINA criteria for mild–moderate asthma. About 89 healthy control nonatopic subjects (HCs) were used as controls.Results:  The frequency of 4G allele was greater in HDM‐AAs (0.69; 95% CI: 0.62–0.76) than in HCs (0.55; 95% CI: 0.48–0.62; P = 0.0034). The PAI‐1 polymorphism was associated with an increased risk of HDM‐AA; adjusted for sex and age odds ratio was 2.62; (95% CI: 1.16–5.92) for 4G/5G genotype and 3.48 (95% CI: 1.54–7.89) for 4G/4G genotype compared with 5G/5G genotype. Total serum immunoglobulin E (tsIgE) level in 4G/4G homozygotes (557 ± 343 kU/l) was significantly greater than in 5G/5G homozygotes (241 ± 288 kU/l; P < 0.001). Both nonspecific and allergen‐specific bronchial reactivities were greater in 4G/4G homozygotes than in 5G/5G homozygotes. 4G/4G genotype was associated with significantly higher morning plasma PAI‐1 concentration in HDM‐AAs and HCs. Morning plasma PAI‐1 concentration correlated significantly with logPC20 (r = −0.39; P = 0.0001) and with logtsIgE (r = 0.247; P = 0.0117).Conclusion:  These results support the hypothesis linking the 4G/4G PAI‐1 genotype with an increased risk of allergic asthma, bronchial hyperreactivity, and increased tsIgE levels.

This publication has 25 references indexed in Scilit: